113.12

22.19% 19.92

Transmedics Group Inc (TMDX)

Overview News Price History Option Chain Financials Why TMDX Down? Discussions Forecast

Transmedics Group Inc stock is traded at $113.12, with a volume of 3.31M. It is up +22.19% in the last 24 hours and up +51.02% over the past month. TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Previous Close:

$93.20

Open:

$114.6

24h Volume:

3.31M

Relative Volume:

2.87

Market Cap:

$3.06B

Revenue:

$401.09M

Net Income/Loss:

$32.64M

P/E Ratio:

120.35

EPS:

0.94

Net Cash Flow:

$-120.51M

1W Performance:

+26.57%

1M Performance:

+51.02%

6M Performance:

+32.45%

1Y Performance:

-11.56%

1-Day Range:

$108.84

$120.93

1-Week Range:

$89.65

$120.93

52-Week Range:

$55.00

$177.37

Transmedics Group Inc Stock (TMDX) Company Profile

Name

Transmedics Group Inc

Sector

Healthcare (1153)

Industry

Medical Devices (155)

Phone

(978) 552-0900

Address

200 MINUTEMAN ROAD, ANDOVER, MA

Employee

728

Twitter

@transmedics

Next Earnings Date

2024-10-28

Latest SEC Filings

TMDX's Discussions on Twitter

Compare TMDX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMDX Transmedics Group Inc	112.98	3.06B	401.09M	32.64M	-120.51M	0.94
ABT Abbott Laboratories	134.51	227.71B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	103.17	152.66B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	382.49	142.93B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	84.09	107.17B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	74.03	44.04B	5.54B	4.18B	623.10M	7.00

Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-17-24	Downgrade	JP Morgan	Overweight → Neutral
Nov-22-24	Downgrade	Needham	Buy → Hold
Oct-29-24	Reiterated	Needham	Buy
Oct-29-24	Reiterated	Oppenheimer	Outperform
Sep-24-24	Initiated	Robert W. Baird	Outperform
Aug-21-24	Initiated	Needham	Buy
Jun-06-24	Initiated	Cantor Fitzgerald	Overweight
Jun-04-24	Initiated	Stephens	Overweight
Mar-28-24	Initiated	Piper Sandler	Overweight
Jul-19-23	Initiated	Robert W. Baird	Outperform
Aug-02-22	Upgrade	JP Morgan	Neutral → Overweight
Oct-08-20	Downgrade	JP Morgan	Overweight → Neutral
Apr-07-20	Initiated	Oppenheimer	Outperform
May-28-19	Initiated	Canaccord Genuity	Buy
May-28-19	Initiated	Cowen	Outperform
May-28-19	Initiated	JP Morgan	Overweight
May-28-19	Initiated	Morgan Stanley	Equal-Weight

View All

Transmedics Group Inc Stock (TMDX) Latest News

12:04 PM

What Analysts Were Expecting After Transmedics Group Inc (NASDAQ: TMDX) rose 22.86% - Stocksregister

12:04 PM

11:30 AM

TransMedics Group (TMDX) Target Price Raised by Piper Sandler | TMDX Stock News - GuruFocus

11:30 AM

11:16 AM

TMDX Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down - Zacks Investment Research

11:16 AM

10:18 AM

Insulet Posts Upbeat Earnings, Joins Trade Desk, TransMedics Group, Tesla And Other Big Stocks Moving Higher On Friday - Benzinga

10:18 AM

09:48 AM

TransMedics: Exceptional Q1 Undermines The Short Narrative (NASDAQ:TMDX) - Seeking Alpha

09:48 AM

03:41 AM